{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:10:09Z","timestamp":1788772209078,"version":"build-2803163510"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009004","name":"Anhui University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Duchenne muscular dystrophy (DMD) is a fatal, X-linked neuromuscular disorder. This study investigated the correlation between serum markers and muscle damage in advanced DMD, retrospectively identified biochemical markers that reflect muscle damage in patients with advanced DMD, and provided a clinical basis for muscle assessment in advanced DMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled 70 male patients with DMD who were treated at the Affiliated Hospital of the Institute of Neurology, Anhui University of Chinese Medicine, between January 2018 and December 2025. They were divided into an advanced group (\u226512 years) and a non-advanced group (&amp;lt;12 years) based on age. We compared differences in serum creatinine (Scr), height-to-creatinine ratio, and creatine kinase (CK) levels between the two groups and used Spearman's rank correlation analysis to assess the association between these indicators and muscle damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The levels of Scr and CK in the advanced group were lower than those in the non-advanced group, while the height-to-creatinine ratio was higher (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). The results of Spearman's rank correlation analysis showed that Scr levels in late-stage DMD were significantly correlated with magnetic resonance imaging (MRI) muscle damage scores (\n                      <jats:italic>r<\/jats:italic>\n                      = \u22120.522,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003), while the height-to-creatinine ratio was significantly positively correlated with MRI scores (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.52,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003). Results of multiple linear regression analysis showed that Scr (\n                      <jats:italic>B<\/jats:italic>\n                      = \u22120.056,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) and the height-to-creatinine ratio (\n                      <jats:italic>B<\/jats:italic>\n                      = \u22120.018,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.047) were independent predictors of the degree of muscle damage in patients with advanced DMD. Scr exhibited the strongest effect (standardized \u03b2 = \u22121.007), with an adjusted\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      of 0.375.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Scr reflects changes in total skeletal muscle mass in patients with advanced DMD. In conjunction with the height-to-creatinine ratio, these parameters provide an assessment indicator for skeletal muscle damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1918003","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:39:39Z","timestamp":1788770379000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of muscle damage in patients with advanced Duchenne muscular dystrophy based on serum creatinine and the height-to-creatinine ratio"],"prefix":"10.3389","volume":"17","author":[{"given":"Binyan","family":"Wan","sequence":"first","affiliation":[{"name":"Anhui University of Chinese Medicine","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huannan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of the Institute of Neurology, Anhui University of Chinese Medicine","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of the Institute of Neurology, Anhui University of Chinese Medicine","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of the Institute of Neurology, Anhui University of Chinese Medicine","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of the Institute of Neurology, Anhui University of Chinese Medicine","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congbo","family":"Sha","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of the Institute of Neurology, Anhui University of Chinese Medicine","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuen","family":"Yu","sequence":"additional","affiliation":[{"name":"Anhui University of Chinese Medicine","place":["Hefei, Anhui, China"]},{"name":"Department of Neurology, Affiliated Hospital of the Institute of Neurology, Anhui University of Chinese Medicine","place":["Hefei, Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e70284","DOI":"10.1002\/jcsm.70284","article-title":"Myonuclear domain-associated and central nucleation-dependent spatial restriction of dystrophin protein expression","volume":"17","author":"Chwalenia","year":"2026","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","article-title":"Identifying non-Duchenne muscular dystrophy-positive and false negative results in prior Duchenne muscular dystrophy newborn screening programs: a review","volume":"73","author":"Gatheridge","year":"2016","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.nmd.2016.09.002","article-title":"Muscle MRI in Duchenne muscular dystrophy: evidence of a distinctive pattern","volume":"26","author":"Polavarapu","year":"2016","journal-title":"Neuromuscul Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nmd.2017.10.003","article-title":"Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: a cross-sectional analysis","volume":"28","author":"Schmidt","year":"2018","journal-title":"Neuromuscul Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e70205","DOI":"10.1002\/jcsm.70205","article-title":"Quantitative MRI Findings and their relationship to muscle histopathology and ambulatory clinical function in Duchenne muscular dystrophy","volume":"17","author":"Lu","year":"2026","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/s41598-025-85369-5","article-title":"Titin fragment is a sensitive biomarker in Duchenne muscular dystrophy model mice carrying full-length human dystrophin gene on human artificial chromosome","volume":"15","author":"Hiramuki","year":"2025","journal-title":"Sci Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1591748","DOI":"10.3389\/fneur.2025.1591748","article-title":"Serum titin\/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies","volume":"16","author":"Nambu","year":"2025","journal-title":"Front Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"141856","DOI":"10.1155\/2015\/141856","article-title":"Serum creatinine level: a supplemental index to distinguish Duchenne muscular dystrophy from Becker muscular dystrophy","volume":"2015","author":"Zhang","year":"2015","journal-title":"Dis Markers."},{"key":"B10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.pcl.2015.03.008","article-title":"Genetics and emerging treatments for Duchenne and Becker muscular dystrophy","volume":"62","author":"Wein","year":"2015","journal-title":"Pediatr Clin North Am."},{"key":"B11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3760\/cma.j.cn112147-20250826-00518","volume":"49","year":"2026","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi."},{"key":"B12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1148\/radiology.186.2.8421754","article-title":"Duchenne muscular dystrophy: MR grading system with functional correlation","volume":"186","author":"Liu","year":"1993","journal-title":"Radiology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"135304","DOI":"10.1016\/j.neulet.2020.135304","article-title":"Alterations of neuromuscular junctions in Duchenne muscular dystrophy","volume":"737","author":"Lovering","year":"2020","journal-title":"Neurosci Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1212\/WNL.33.2.158","article-title":"The assessment of muscle mass in progressive neuromuscular disease","volume":"33","author":"Griggs","year":"1983","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"120053","DOI":"10.1016\/j.cca.2024.120053","article-title":"Urinary titin reflects the severity of walking ability, muscle strength, and muscle and cardiac damage in patients with Becker muscular dystrophy","volume":"566","author":"Awano","year":"2025","journal-title":"Clin Chim Acta."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12883-021-02382-7","article-title":"Serum creatinine as a biomarker for dystrophinopathy: a cross-sectional and longitudinal study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/jcsm.12969","article-title":"Muscle mass and estimates of renal function: a longitudinal cohort study","volume":"13","author":"Groothof","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1697907","DOI":"10.3389\/fendo.2025.1697907","article-title":"Endocrine and metabolic complications in a national cohort of Slovene children and adolescents with Duchenne muscular dystrophy: real-world criteria for transition to vamorolone therapy","volume":"16","author":"Jazbin\u0161ek","year":"2025","journal-title":"Front Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0254649","DOI":"10.1371\/journal.pone.0254649","article-title":"Causal linkage between adult height and kidney function: an integrated population-scale observational analysis and Mendelian randomization study","volume":"16","author":"Park","year":"2021","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00467-022-05810-z","article-title":"Relation between obesity-related comorbidities and kidney function estimation in children","volume":"38","author":"van Dam","year":"2023","journal-title":"Pediatr Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s10157-011-0452-y","article-title":"Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study","volume":"15","author":"Uemura","year":"2011","journal-title":"Clin Exp Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"13956","DOI":"10.4081\/ejtm.2025.13956","article-title":"Serum protein biomarker signature of Duchenne muscular dystrophy","volume":"35","author":"Dowling","year":"2025","journal-title":"Eur J Transl Myol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/mus.27760","article-title":"A longitudinal study of creatine kinase and creatinine levels in Duchenne muscular dystrophy","volume":"67","author":"Zygmunt","year":"2023","journal-title":"Muscle Nerve."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijmm.2017.2952","article-title":"Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy","volume":"39","author":"Murphy","year":"2017","journal-title":"Int J Mol Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"921785","DOI":"10.3389\/fneur.2022.921785","article-title":"Novel miRNA Biomarkers for patients with Duchenne muscular dystrophy","volume":"13","author":"Meng","year":"2022","journal-title":"Front Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1918003\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:39:41Z","timestamp":1788770381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1918003\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":27,"alternative-id":["10.3389\/fneur.2026.1918003"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1918003","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"1918003"}}